← Open Payments lookup

ADAM SAGOT: Open Payments

NPI 1154707495 · NEPTUNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$500 in 27 payments from 9 companies in 2025. Trend: 2023 $567 · 2024 $895 · 2025 $500

Food & beverage: $500
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$177
Janssen Pharmaceuticals, Inc6$107
Teva Pharmaceuticals USA, Inc.3$50
Neurocrine BioSciences, Inc.2$43
Vanda Pharmaceuticals Inc.2$35
Otsuka America Pharmaceutical, Inc.2$30
E.R. Squibb & Sons, L.L.C.1$21
Alkermes, Inc.1$20
Axsome Therapeutics, Inc.1$17

Products named: CAPLYTA, INVEGA SUSTENNA, INGREZZA, SPRAVATO, FANAPT, AUSTEDO XR, COBENFY, ARISTADA.

Industry payments across NJ — which companies pay providers there.